PharmaVOICE - 
January 2010
Purchase Issue

In Every Issue
Last Word
taking stock of the media After the two-day hearing, do [...]
By
Talent Pool
Biotechnology POOL Dr. Diane JORKASKY Aileron Therapeutics Appoints Medical Chief [...]
By
E-media
E-upgrades and enhancements Prolifiq’s recent software release, Prolifiq for Life [...]
By
What’s New
Oncology Performance Edge, Health Strategies Group’s recently launched strategic research [...]
By
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: [...]
By
UpFront
Honors and Awards GCPj Bestows Honors The Global Clinical Practices [...]
By
Letter from the Editor
Publisher Lisa Banket Editor Taren Grom Creative Director Marah Walsh [...]
By

On The Cover

Incentive Compensation
As the new environment of pharma sales shifts to more specialized and consumer-centric approaches, the industry will need to respond to ­adequately compensate and incentivize its sales teams. Our experts say prescription numbers will remain the predominant measurement for sales rep performance in the near term, but eventually, the industry will have to create IC [...]
By

Robin Robinson

Features

Partners in Public Health
The first influenza pandemic of the 21st century is under way. H1N1 influenza A has affected more than 207 countries and overseas territories worldwide, according the World Health Organization. As of the end of November 2009, 622,482 cases have been reported, including more than 7,820 deaths. In April 2009, the WHO declared the virus a [...]
By

Denise Myshko

Executive Coaching
The goal of coaching is the goal of good ­management: and that is to make the most of an organization’s valuable resources — ­Harvard Business Review he International Coach Federation (ICF), one of the largest worldwide resources for professional coaches, defines coaching as partnering with clients in a thought-provoking and creative process that inspires them [...]
By

Taren Grom, Editor

Dr. Thomas Steitz: The Right Chemistry
Brilliance begets brilliance, and from early in his career, Thomas Steitz, Ph.D., has learned from and kept company with some of the most highly lauded scientific minds of the 20th and 21st centuries. Over the years, breakthrough discoveries regarding the ribosome have led to Dr. Steitz being often cited and honored by his peers as [...]
By

Kim Ribbink

Pharmaceutical Manufacturing Under Scrutiny
Across the board — from labeling and marketing, to clinical trials, to manufacturing processes — regulators are becoming more active in safeguarding the public and ensuring the safety of pharmaceuticals. Even before the news broke regarding Genzyme Corp.’s recent virus and contamination problems (bits of steel, rubber, and fiber were found in drugs made by [...]
By

Denise Myshko

Name That Brand: A Pilot Program
The eventual outcome of the FDA’s two-year Proprietary Name Review pilot project may have positive implications for the industry in the long run, but in the short term, it means more money spent and more time pressure for marketers. Our experts say the burden on pharma companies to conduct their own testing and evaluation will [...]
By

Robin Robinson

FEEDBACK